-
1
-
-
84924271853
-
Global cancer statistics, 2012
-
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. (2015) Global cancer statistics, 2012. CA Cancer J Clin.
-
(2015)
CA Cancer J Clin
-
-
Torre, L.A.1
Bray, F.2
Siegel, R.L.3
Ferlay, J.4
Lortet-Tieulent, J.5
Jemal, A.6
-
3
-
-
0038299190
-
Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making
-
12879467
-
Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN (2003) Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer 98:508-515. PMID: 12879467
-
(2003)
Cancer
, vol.98
, pp. 508-515
-
-
Greenberg, J.S.1
El Naggar, A.K.2
Mo, V.3
Roberts, D.4
Myers, J.N.5
-
4
-
-
0037333273
-
Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas
-
12620571
-
Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, et al. (2003) Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185:278-284. PMID: 12620571
-
(2003)
Am J Surg
, vol.185
, pp. 278-284
-
-
Shingaki, S.1
Takada, M.2
Sasai, K.3
Bibi, R.4
Kobayashi, T.5
Nomura, T.6
-
5
-
-
78650626081
-
The molecular biology of head and neck cancer
-
21160525
-
Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9-22. doi: 10.1038/nrc2982 PMID: 21160525
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 9-22
-
-
Leemans, C.R.1
Braakhuis, B.J.2
Brakenhoff, R.H.3
-
6
-
-
19944428510
-
Novel markers for poor prognosis in head and neck cancer
-
15499618
-
Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, et al. (2005) Novel markers for poor prognosis in head and neck cancer. Int J Cancer 113:789-797. PMID: 15499618
-
(2005)
Int J Cancer
, vol.113
, pp. 789-797
-
-
Chin, D.1
Boyle, G.M.2
Williams, R.M.3
Ferguson, K.4
Pandeya, N.5
Pedley, J.6
-
7
-
-
16844379997
-
Immunosuppressive networks in the tumour environment and their therapeutic relevance
-
15776005
-
Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263-274. PMID: 15776005
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 263-274
-
-
Zou, W.1
-
8
-
-
84873534154
-
The role of B7 family molecules in hematologic malignancy
-
23223433
-
Greaves P, Gribben JG (2013) The role of B7 family molecules in hematologic malignancy. Blood 121:734-744. doi: 10.1182/blood-2012-10-385591 PMID: 23223433
-
(2013)
Blood
, vol.121
, pp. 734-744
-
-
Greaves, P.1
Gribben, J.G.2
-
9
-
-
0027078670
-
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
-
1335364
-
Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, et al. (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093-1102. PMID: 1335364
-
(1992)
Cell
, vol.71
, pp. 1093-1102
-
-
Chen, L.1
Ashe, S.2
Brady, W.A.3
Hellstrom, I.4
Hellstrom, K.E.5
Ledbetter, J.A.6
-
10
-
-
77953747963
-
The PD-1 pathway in tolerance and autoimmunity
-
20636820
-
Francisco LM, Sage PT, Sharpe AH (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236:219-242. doi: 10.1111/j.1600-065X.2010.00923.x PMID: 20636820
-
(2010)
Immunol Rev
, vol.236
, pp. 219-242
-
-
Francisco, L.M.1
Sage, P.T.2
Sharpe, A.H.3
-
11
-
-
0038273853
-
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
-
12704383
-
Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, et al. (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9:562-567. PMID: 12704383
-
(2003)
Nat Med
, vol.9
, pp. 562-567
-
-
Curiel, T.J.1
Wei, S.2
Dong, H.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
-
12
-
-
33645846313
-
Tissue expression of PD-L1 mediates peripheral T cell tolerance
-
16606670
-
Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, et al. (2006) Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 203:883-895. PMID: 16606670
-
(2006)
J Exp Med
, vol.203
, pp. 883-895
-
-
Keir, M.E.1
Liang, S.C.2
Guleria, I.3
Latchman, Y.E.4
Qipo, A.5
Albacker, L.A.6
-
13
-
-
42649125225
-
PD-1 and its ligands in tolerance and immunity
-
18173375
-
Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677-704. doi: 10.1146/annurev. immunol.26.021607.090331 PMID: 18173375
-
(2008)
Annu Rev Immunol
, vol.26
, pp. 677-704
-
-
Keir, M.E.1
Butte, M.J.2
Freeman, G.J.3
Sharpe, A.H.4
-
14
-
-
18544380239
-
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
-
12091876
-
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793-800. PMID: 12091876
-
(2002)
Nat Med
, vol.8
, pp. 793-800
-
-
Dong, H.1
Strome, S.E.2
Salomao, D.R.3
Tamura, H.4
Hirano, F.5
Flies, D.B.6
-
15
-
-
43549115533
-
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
-
18223165
-
Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L (2008) B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 111:3635-3643. doi: 10.1182/blood-2007-11-123141 PMID: 18223165
-
(2008)
Blood
, vol.111
, pp. 3635-3643
-
-
Azuma, T.1
Yao, S.2
Zhu, G.3
Flies, A.S.4
Flies, S.J.5
Chen, L.6
-
16
-
-
4243096258
-
B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
-
15297412
-
Konishi J, Yamazaki K, Azuma M, Kinoshita I, Dosaka-Akita H, Nishimura M (2004) B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res 10:5094-5100. PMID: 15297412
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5094-5100
-
-
Konishi, J.1
Yamazaki, K.2
Azuma, M.3
Kinoshita, I.4
Dosaka-Akita, H.5
Nishimura, M.6
-
17
-
-
20244384862
-
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
-
15837746
-
Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, et al. (2005) Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res 11:2947-2953. PMID: 15837746
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2947-2953
-
-
Ohigashi, Y.1
Sho, M.2
Yamada, Y.3
Tsurui, Y.4
Hamada, K.5
Ikeda, N.6
-
18
-
-
0141953992
-
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma
-
14559843
-
Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K, et al. (2003) B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 63:6501-6505. PMID: 14559843
-
(2003)
Cancer Res
, vol.63
, pp. 6501-6505
-
-
Strome, S.E.1
Dong, H.2
Tamura, H.3
Voss, S.G.4
Flies, D.B.5
Tamada, K.6
-
19
-
-
10344220548
-
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
-
15569934
-
Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al. (2004) Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A 101:17174-17179. PMID: 15569934
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 17174-17179
-
-
Thompson, R.H.1
Gillett, M.D.2
Cheville, J.C.3
Lohse, C.M.4
Dong, H.5
Webster, W.S.6
-
20
-
-
0242442492
-
Expression of the B7-related molecule B7-H1 by glioma cells: A potential mechanism of immune paralysis
-
14612546
-
Wintterle S, Schreiner B, Mitsdoerffer M, Schneider D, Chen L, Meyermann R, et al. (2003) Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res 63:7462-7467. PMID: 14612546
-
(2003)
Cancer Res
, vol.63
, pp. 7462-7467
-
-
Wintterle, S.1
Schreiner, B.2
Mitsdoerffer, M.3
Schneider, D.4
Chen, L.5
Meyermann, R.6
-
21
-
-
33646367200
-
The B7-H1 (PDL1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: Correlation with important high-risk prognostic factors
-
16611412
-
Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G, et al. (2006) The B7-H1 (PDL1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia 8:190-198. PMID: 16611412
-
(2006)
Neoplasia
, vol.8
, pp. 190-198
-
-
Ghebeh, H.1
Mohammed, S.2
Al-Omair, A.3
Qattan, A.4
Lehe, C.5
Al-Qudaihi, G.6
-
22
-
-
84897404380
-
Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes
-
24548766
-
Yang CY, Lin MW, Chang YL, Wu CT, Yang PC (2014) Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes. Eur J Cancer 50:1361-1369. doi: 10.1016/j.ejca.2014.01.018 PMID: 24548766
-
(2014)
Eur J Cancer
, vol.50
, pp. 1361-1369
-
-
Yang, C.Y.1
Lin, M.W.2
Chang, Y.L.3
Wu, C.T.4
Yang, P.C.5
-
23
-
-
33645736792
-
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
-
16585157
-
Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, et al. (2006) Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 66:3381-3385. PMID: 16585157
-
(2006)
Cancer Res
, vol.66
, pp. 3381-3385
-
-
Thompson, R.H.1
Kuntz, S.M.2
Leibovich, B.C.3
Dong, H.4
Lohse, C.M.5
Webster, W.S.6
-
24
-
-
34247532726
-
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
-
17404099
-
Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, et al. (2007) Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res 13:2151-2157. PMID: 17404099
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2151-2157
-
-
Nomi, T.1
Sho, M.2
Akahori, T.3
Hamada, K.4
Kubo, A.5
Kanehiro, H.6
-
25
-
-
84859128199
-
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
-
Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, et al. (2012) Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 4:127ra137.
-
(2012)
Sci Transl Med
, vol.4
, pp. 127ra137
-
-
Taube, J.M.1
Anders, R.A.2
Young, G.D.3
Xu, H.4
Sharma, R.5
McMiller, T.L.6
-
26
-
-
84871414810
-
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Federation Francophone de Cancerologie Digestive 9601
-
22926014
-
Ferrand F, Malka D, Bourredjem A, Allonier C, Bouche O, Louafi S, et al. (2013) Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Federation Francophone de Cancerologie Digestive 9601. Eur J Cancer 49:90-97. doi: 10.1016/j.ejca.2012.07.006 PMID: 22926014
-
(2013)
Eur J Cancer
, vol.49
, pp. 90-97
-
-
Ferrand, F.1
Malka, D.2
Bourredjem, A.3
Allonier, C.4
Bouche, O.5
Louafi, S.6
-
27
-
-
84869756365
-
Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma
-
23185547
-
Chen CJ, Sung WW, Lin YM, Chen MK, Lee CH, Lee H, et al. (2012) Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma. PLoS One 7:e50104. doi: 10.1371/journal. pone.0050104 PMID: 23185547
-
(2012)
PLoS One
, vol.7
, pp. e50104
-
-
Chen, C.J.1
Sung, W.W.2
Lin, Y.M.3
Chen, M.K.4
Lee, C.H.5
Lee, H.6
-
28
-
-
84866673992
-
High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients
-
22981868
-
Chen CJ, Sung WW, Su TC, Chen MK, Wu PR, Yeh KT, et al. (2013) High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients. Clin Chim Acta 415:25-30. doi: 10.1016/j.cca.2012.09.009 PMID: 22981868
-
(2013)
Clin Chim Acta
, vol.415
, pp. 25-30
-
-
Chen, C.J.1
Sung, W.W.2
Su, T.C.3
Chen, M.K.4
Wu, P.R.5
Yeh, K.T.6
-
29
-
-
84924708539
-
High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
-
25511643
-
Sung WW, Lin YM, Wu PR, Yen HH, Lai HW, Su TC, et al. (2014) High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients. BMC Cancer 14:951. doi: 10. 1186/1471-2407-14-951 PMID: 25511643
-
(2014)
BMC Cancer
, vol.14
, pp. 951
-
-
Sung, W.W.1
Lin, Y.M.2
Wu, P.R.3
Yen, H.H.4
Lai, H.W.5
Su, T.C.6
-
30
-
-
80052825094
-
A polymorphic-844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer
-
21807637
-
Sung WW, Wang YC, Cheng YW, Lee MC, Yeh KT, Wang L, et al. (2011) A polymorphic-844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer. Clin Cancer Res 17:5991-5999. doi: 10.1158/1078-0432. CCR-11-0227 PMID: 21807637
-
(2011)
Clin Cancer Res
, vol.17
, pp. 5991-5999
-
-
Sung, W.W.1
Wang, Y.C.2
Cheng, Y.W.3
Lee, M.C.4
Yeh, K.T.5
Wang, L.6
-
31
-
-
84881256573
-
IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma
-
23743567
-
Sung WW, Wang YC, Lin PL, Cheng YW, Chen CY, Wu TC, et al. (2013) IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma. Clin Cancer Res 19:4092-4103. doi: 10.1158/1078-0432. CCR-12-3439 PMID: 23743567
-
(2013)
Clin Cancer Res
, vol.19
, pp. 4092-4103
-
-
Sung, W.W.1
Wang, Y.C.2
Lin, P.L.3
Cheng, Y.W.4
Chen, C.Y.5
Wu, T.C.6
-
32
-
-
78649356076
-
Optimal treatment for recurrent/metastatic head and neck cancer
-
20943624
-
Vermorken JB, Specenier P (2010) Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol 21 Suppl 7:vii252-261. doi: 10.1093/annonc/mdq453 PMID: 20943624
-
(2010)
Ann Oncol
, vol.21
, pp. vii252-vii261
-
-
Vermorken, J.B.1
Specenier, P.2
-
33
-
-
35548961447
-
A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects
-
17914078
-
Strome SE, Sausville EA, Mann D (2007) A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects. Oncologist 12:1084-1095. PMID: 17914078
-
(2007)
Oncologist
, vol.12
, pp. 1084-1095
-
-
Strome, S.E.1
Sausville, E.A.2
Mann, D.3
-
34
-
-
84877096819
-
Cetuximabactivated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients
-
23444227
-
Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson HC, et al. (2013) Cetuximabactivated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients. Clin Cancer Res 19:1858-1872. doi: 10.1158/1078-0432. CCR-12-2426 PMID: 23444227
-
(2013)
Clin Cancer Res
, vol.19
, pp. 1858-1872
-
-
Srivastava, R.M.1
Lee, S.C.2
Andrade Filho, P.A.3
Lord, C.A.4
Jie, H.B.5
Davidson, H.C.6
-
35
-
-
84862903106
-
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
-
22658128
-
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366:2455-2465. doi: 10.1056/NEJMoa1200694 PMID: 22658128
-
(2012)
N Engl J Med
, vol.366
, pp. 2455-2465
-
-
Brahmer, J.R.1
Tykodi, S.S.2
Chow, L.Q.3
Hwu, W.J.4
Topalian, S.L.5
Hwu, P.6
-
36
-
-
84862859820
-
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
-
22658127
-
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443-2454. doi: 10. 1056/NEJMoa1200690 PMID: 22658127
-
(2012)
N Engl J Med
, vol.366
, pp. 2443-2454
-
-
Topalian, S.L.1
Hodi, F.S.2
Brahmer, J.R.3
Gettinger, S.N.4
Smith, D.C.5
McDermott, D.F.6
-
37
-
-
84862882003
-
Tumor immunotherapy directed at PD-1
-
22658126
-
Ribas A (2012) Tumor immunotherapy directed at PD-1. N Engl J Med 366:2517-2519. doi: 10.1056/NEJMe1205943 PMID: 22658126
-
(2012)
N Engl J Med
, vol.366
, pp. 2517-2519
-
-
Ribas, A.1
-
38
-
-
84920511157
-
Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer-review of current data
-
25459157
-
Swanson MS, Sinha UK (2015) Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer-review of current data. Oral Oncol 51:12-15. doi: 10.1016/j. oraloncology.2014.10.010 PMID: 25459157
-
(2015)
Oral Oncol
, vol.51
, pp. 12-15
-
-
Swanson, M.S.1
Sinha, U.K.2
-
39
-
-
84888642382
-
Promising systemic immunotherapies in head and neck squamous cell carcinoma
-
24126223
-
Gildener-Leapman N, Ferris RL, Bauman JE (2013) Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol 49:1089-1096. doi: 10.1016/j.oraloncology.2013.09.009 PMID: 24126223
-
(2013)
Oral Oncol
, vol.49
, pp. 1089-1096
-
-
Gildener-Leapman, N.1
Ferris, R.L.2
Bauman, J.E.3
|